In an advancement by the Hannon lab at CSHL, it is now possible to profile normal and cancerous mammary stem cells at an unprecedented high degree of purity. This may help identify genes that should be investigated as the next breast cancer drug targets.
Fuente : http://www.eurekalert.org/pub_releases/2013-04/csh...
Fuente : http://www.eurekalert.org/pub_releases/2013-04/csh...